Chinese medicinal composition for treating ascites due to cirrhosis

A technology for liver cirrhosis ascites and composition, which is applied in the directions of drug combination, digestive system, pharmaceutical formula, etc., can solve the problems of general curative effect, insignificant effect, delay in illness, etc., and achieves improvement of cure rate and survival rate, and reasonable composition of components. Effective, low-cost effects

Inactive Publication Date: 2013-02-13
张秋怀
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are many ways to treat liver cirrhosis ascites in clinical practice. Western medicine is generally effective, and its side effects are large, which will bring a greater burden to liver function and even aggravate the condition of the liver. Moreover, many families of patients cannot afford the treatment of western medicine. Huge cost
If traditional Chinese medicine is used for treatment, not only the effect is slow, but the effect is not significant, which delays the progress of the disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Take 20 parts of astragalus, 5 parts of ginseng, 10 parts of Atractylodes macrocephala, 10 parts of poria cocos, 10 parts of salvia miltiorrhiza, 10 parts of vinegar turtle, 20 parts of Dabupi, 10 parts of Eupatorium, 10 parts of Alisma, 20 parts of plantago, 20 parts of Polyporus, 10 parts of Fangji and 5 parts of Panax notoginseng, the above raw materials were prepared into 500 parts of water decoction, taken twice a day, 250ml each time.

Embodiment 2

[0015] Take 100 parts of astragalus, 20 parts of ginseng, 40 parts of Atractylodes macrocephala, 30 parts of Poria cocos bark, 30 parts of salvia miltiorrhiza, 40 parts of vinegar turtle, 50 parts of Dabupi, 20 parts of Eupatorium, 20 parts of Alisma, 40 parts of plantago, 40 parts of polyporus, 20 parts of Fangji and 10 parts of Panax notoginseng. The above-mentioned raw materials are prepared into 500 parts of water decoctions, which are taken twice a day, 250ml each time.

Embodiment 3

[0017] Take 80 parts of astragalus, 15 parts of ginseng, 20 parts of Atractylodes macrocephala, 15 parts of Poria cocos bark, 15 parts of salvia miltiorrhiza, 20 parts of vinegar turtle, 35 parts of Dabupi, 15 parts of Eupatorium, 15 parts of Alisma, 30 parts of plantago, 30 parts of Polyporus, 15 parts of Fangji and 8 parts of Panax notoginseng. The above-mentioned raw materials are prepared into 500 parts of water decoctions, which are taken twice a day, 250ml each time.

[0018] Effect example

[0019] 1. Basis for diagnosis

[0020] 1.1 At the beginning, the abdominal cavity is distended, and the abdomen is distended, especially after eating. In severe cases, the abdominal distention is higher than that of the chest. In severe cases, the veins on the abdominal wall are exposed, and the umbilical foramen is prominent, often accompanied by fatigue, loss of appetite, oliguria, and edema.

[0021] 1.2 Jaundice, liver palms, spider nevus; drumming sound on percussion, dec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of Chinese medicament, and in particular relates to a Chinese medicinal composition for treating ascites due to cirrhosis. The Chinese medicinal composition is prepared form astragalus mongholicus, ginseng, bighead atractylodes rhizome, poria peel, red-rooted salvia root, vinegar turtle, areca peel, herba lycopi, oriental water plantain rhizome, plantain seed, polyporus umbrellatus, stephania tetrandra and pseudo-ginseng. Pharmaceutical conventional preparations can be prepared from the raw materials in a conventional method. The Chinese medicinal composition is low in cost, simple in prescription and reasonable and effective in component compatibility, can perform treatment and vital energy invigoration at the same time with remarkable curative effect, so that the cure rate and survival rate of patients suffering from ascites due to cirrhosis can be improved.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating liver cirrhosis ascites. Background technique [0002] Cirrhosis is a common chronic, progressive, diffuse liver disease caused by one or more etiologies. There are many pathogenic factors, and liver cirrhosis caused by viral hepatitis is the most common in China. Its pathological features are liver cell degeneration, necrosis, diffuse proliferation of fibrous tissue, and the formation of regenerative nodules, resulting in damage to the structure of liver lobules and hepatic vascular anatomy, gradually deforming and hardening the liver, and eventually developing into cirrhosis. Hepatic ascites complications can also occur in advanced cirrhosis. According to literature reports, the annual incidence rate of liver cirrhosis developed from chronic hepatitis B is 2.1%. The 5-year mortality rates of chronic hepatiti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/884A61P1/16A61P7/10A61K35/56A61K35/586
Inventor 张秋怀
Owner 张秋怀
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap